If you eat carefully, work on your feet all day, and still watch weight settle stubbornly around your middle, it is fair to suspect something beyond willpower. The good news: there are specific labs that can help explain what is happening long before a routine glucose test looks abnormal.
Why the scale (and a normal glucose) can miss the story
When weight sits around the waist alongside irregular cycles, acne, and relentless cravings, one common thread worth exploring is insulin resistance: a state where the body has to make more insulin to keep blood sugar in a normal range. Here is the catch. Fasting glucose can stay normal for years while insulin quietly climbs to keep it there [1]. That is why being told to "just lose weight" without a lab panel can feel so hollow. The compensation is invisible on the tests most often ordered.
Insulin resistance is also closely tied to the cluster called metabolic syndrome, which includes elevated waist circumference, elevated triglycerides, low HDL cholesterol, elevated blood pressure, and elevated fasting glucose [2]. You do not need all five for the pattern to matter. The point is that these markers travel together, and some of them shift earlier than glucose does.
Source: [2] Harmonizing the Metabolic Syndrome: A Joint Interim Statement
The triglyceride-to-HDL ratio: a quiet early signal
Most people already have triglycerides and HDL cholesterol on a standard lipid panel. Fewer realize that the *ratio* between them has been studied as a surrogate marker for insulin resistance. In research on adults, a higher triglyceride-to-HDL ratio has been associated with insulin resistance and with the small, dense LDL particles linked to cardiovascular risk [3][4].
The reason is mechanistic, not magic. When insulin is not working efficiently, the liver tends to produce more triglyceride-rich particles, and HDL cholesterol tends to fall. So triglycerides drift up while HDL drifts down, and the ratio widens. It is a pattern you can sometimes read on a panel you may already have in a drawer.
A few honest caveats. The ratio's usefulness varies by population, and it performs differently across ancestries, so it is a conversation-starter, not a diagnosis [4]. Units matter too: the commonly cited thresholds in U.S. studies use mg/dL for both values. Any interpretation belongs to a licensed provider looking at your full picture, not to a number in isolation.
Fasting insulin: measuring the effort, not just the result
Fasting glucose tells you the *result* your body achieved. Fasting insulin hints at how hard it worked to get there. Researchers combine the two into a calculation called HOMA-IR (fasting glucose times fasting insulin, divided by a constant) as an estimate of insulin resistance [1][5].
This matters for the exact situation of stubborn central weight with normal glucose. A person can have a "normal" fasting glucose while fasting insulin and HOMA-IR are elevated, suggesting the system is compensating hard behind the scenes [1]. Fasting insulin is not a perfect standalone test, and lab reference ranges vary, but paired with the lipid ratio and a waist measurement it can add real texture to a story the scale alone cannot tell.
Where irregular cycles fit in
Irregular cycles, acne, and central weight often prompt providers to consider polycystic ovary syndrome (PCOS), which international guidelines describe as frequently involving insulin resistance regardless of body size [6]. That is why a metabolic workup, not just a weight lecture, is often the more useful first step. Investigating the metabolic side is educational context here, not a diagnosis of you.
What you can reasonably ask to have checked first
You are not asking for anything exotic. A focused, affordable starting panel that an independent provider may consider often includes:
- A fasting lipid panel (so triglycerides and HDL can be seen, and the ratio calculated) [3]
- Fasting insulin and fasting glucose (which together allow a HOMA-IR estimate) [1][5]
- Hemoglobin A1c (a longer-term glucose average that can flag prediabetes ranges) [7]
- Waist circumference, a simple, free measurement tied to metabolic risk [2]
For context on where numbers land, the ADA defines prediabetes as an A1c of 5.7 to 6.4 percent, a fasting glucose of 100 to 125 mg/dL, or a 2-hour glucose of 140 to 199 mg/dL [7]. Seeing these values written down, rather than being told "you're fine" or "just lose weight," is often the difference between guessing and understanding.
% A1c · marker = Prediabetes starts
Source: [7] ADA Standards of Care: Classification and Diagnosis of Diabetes
Reading results without spiraling
A single elevated ratio or a borderline insulin does not define you, and no lab replaces a clinician's judgment. Labs drift with recent meals, illness, sleep, and stress, which is why fasting timing and repeat testing matter. The value of these markers is that they can turn a frustrating, shame-laced conversation into a specific one: here is a pattern, here is what it may reflect, and here is what an independent provider might monitor over time.
It is also worth naming what these labs are *not*. They are not a green light for any particular medication. Whether any treatment (oral or otherwise) is appropriate is a decision only an independent, licensed provider can make after reviewing your history and labs. Some metabolic approaches discussed in telehealth are compounded. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. A prescription is never guaranteed.
Source: [7] ADA Standards of Care: Classification and Diagnosis of Diabetes
Bringing it to a real conversation
If you have felt dismissed, a lab-first framing gives you language. You can say: "I would like to look at my triglyceride-to-HDL ratio, a fasting insulin with glucose, and an A1c, because I want to understand the metabolic side, not just the number on the scale." That request is reasonable, specific, and grounded in how these markers actually behave.
This article is educational and is not medical advice, diagnosis, or a recommendation to take any specific medication. Use it to have a better conversation with a licensed provider.
Where Velri fits
Velri is a technology and coordination company, not a medical practice. Velri does not provide medical care and employs no physicians. What Velri can do is help coordinate the practical steps: arranging lab work, connecting you with an independent, physician-led Provider Group for a visit, and, if (and only if) an independent licensed provider determines it is appropriate, coordinating with an independent licensed pharmacy. The Velri clinical review process is designed to make sure a real provider looks at your labs and your history. Any decision about testing or treatment rests entirely with that independent provider. Coverage currently starts in Nevada, with more states rolling out over time.
